ABSTRACT MUC1, a mucin-like transmembrane glycoprotein, is highly overexpressed and aberrantly localized in several invasive carcinomas. MUC1 is proposed to play numerous roles in the transformed behaviour of cells in which it is expressed. A number of these roles are facilitated by the interaction of MUC1 with β-catenin, a protein that is central to both cellular adhesion as well as Wnt-responsive gene transcription. The aim of this study was to investigate MUC1 expression, localization, and interaction with β-catenin, as a means of providing insight into the behaviour of human oesophageal squamous cell carcinoma. This cancer-type is exceptionally aggressive and is a major cause of cancer-related morbidity and mortality in South Africa. MUC1 is expressed and aberrantly localized in oesophageal squamous cell carcinoma cell lines, as demonstrated by RT-PCR, western blotting and indirect immunofluorescence. Moreover, evidence from coimmunoprecipitation assays shows that the MUC1 cytoplasmic tail and β-catenin form a complex both at the cell membrane and importantly, within the nucleus of these cell lines. This is the first demonstration of such a complex in the nucleus of a carcinoma derived from stratified, as opposed to simple, epithelia. Data presented here further indicates that activation of the epidermal growth factor receptor results in modulation of the association between MUC1 and β-catenin at the cell membrane. MUC1 membrane-localization, and interaction with β-catenin, may modulate cellular adhesion through steric interference of cell surface adhesion molecules as well as through sequestration of β-catenin away from adherens junctions. On the other hand, MUC1 association with β-catenin may enhance β- catenin signalling either through the stabilization of β-catenin, or as an essential functional component of the β-catenin/LEF/TCF transcription factor complex. Furthermore, results presented in this study identify oesophageal squamous cell carcinoma as a prime candidate for MUC1-specific immunotherapy. This finding is of substantial importance considering the ineffectual nature of existing therapies used in the treatment of oesophageal carcinoma.

1 / Rongrong Zhang

No description available.

b-catenin plays a dual role as a structural component of adherens junctions and as a transcriptional coactivator through its interactions with E-cadherin and TCF/LEF transcription factors, respectively. Normally, free b-catenin in cytoplasma is regulated by proteosome-dependent degradation system. In malignant tumor cell , deregulation of b-catenin degradation results in its aberrant accumulation, and leading to cancer. The goals of this study were to explore the reason of aberrant b-catenin accumulation in cervical carcinoma and evaluate the correlation between b-catenin¡BE-cadherin and p53 in different FIGO stage. Seventy paraffin embedded specimen with different FIGO stage were included in this study. Immunohistochemical staining was performed using anti-b-catenin polyclonal antibody and anti-p53 polyclonal antibody respectively and direct sequencing methods to analyze the mutation of CTNNB1 exon 13. The results showed 58 cases (82.8%) displayed cytoplasmic/nuclear b-catenin and no mutations in exon 13 of b-catenin gene, whereas no significant correlation between b-catenin expression level and tumor metastasis. However, b-catenin expression intensity had significant correlation with tumor size (p=0.008) and inversely correlated with E-cadherin (p=0.027) in different FIGO stage. The other way, the p53 staining intensity was significant correlated with b-catenin expression intensity (p=0.013) . Therefore, we suggest that mutations of CTNNB1 exon 13 may not be a reason for aberrant b-catenin accumulation in cervical carcinoma and aberrant p53 may play an important factor in accumulation of b-catenin.

Thesis (Ph. D.)--University of Washington, 2007. / Vita. Includes bibliographical references (leaves 55-69).

Thesis (Ph. D.)--University of Washington, 2007. / Vita. Includes bibliographical references (leaves 55-62).

The development of complex metazoans depends on the integration of a handful of signalling pathways that eventually modulate precise patterns of gene expression. The fact that just a few pathways are involved in the generation of such complexity in different organisms, suggests that these are highly regulated and conserved processes. The accurate spatio-temporal coordination of the signalling pathways controls the assignation of different cell fates and their patterning into tissues and organs. The source of diversity relies on the different possible interactions between signalling pathways, such as, the combination of signals and the order in which they are received by the cell or crosstalk. Due to their importance in development, abnormal signalling through these pathways has been strongly associated with developmental disorders, cancers and other diseases. The Notch and Wnt signalling pathways are key components of the intricate network that controls gene expression during development, and genetic analysis in Drosophila has highlighted that interactions between these two signalling pathways are important during this process.This thesis investigates the cross-regulatory interactions between Notch and Wnt signalling pathways in mammals. Using transcriptional reporter assays and biochemical analysis, I have found two molecular mechanisms underlying the inhibitory crosstalk between Notch and β-catenin, the effector of Wnt signalling pathway, in mammalian cells. At the membrane Notch inhibits β-catenin transcriptional activity through Deltex mediated endocytosis of Notch and a component required for β-catenin activation. This is similar to results observed in Drosophila. In the nucleus, I have identified a novel mechanism by which NICD-dependent transcription of Hes/Hey family of transcription factors prevents the activation of Wnt signalling pathway. This mechanism involves the formation of a physical complex between Hey1 and β-catenin/TCF, which allows Hey to block Wnt transcriptional activation. Additionally, I have found that these two mechanisms are conserved across vertebrates.Together the findings of this thesis improve our understanding of the molecular mechanism underlying the Notch/Wnt crosstalk. In turn, this will give an insight into unravelling how a handful of signalling pathways can generate sufficient diversity in signalling output to specify the hundreds of different cell fates generated to make a mammal. Elucidating these signalling networks will also contribute to our understanding of diseases, both their aetiology, by knowing how changes in one signal can influence another, and their treatment as mimicking points of crosstalk is likely to generate very specific therapeutic agents.

The anterior pituitary gland is the major hormonal regulator in the body. The gland contains five secretory cell types whose emergence during development is defined by a tightly regulated array of transcription factors. In adult life, the gland is plastic with the relative proportions of cells varying depending on physiological context. Tumours of the pituitary gland account for 15% of all intracranial tumours in man and are caused by the selective proliferation of one of the secretory cell types. The majority of these (60%) are prolactinomas which consist of very slowly proliferating lactotroph cells, which produce the hormone prolactin. Pituitary tumours are almost never malignant and do not express common genetic markers for cancer, suggesting endogenous proliferative stimuli in the pituitary are the cause of tumour development. Oestrogen causes lactotroph hyperplasia during pregnancy and increases prolactin secretion. Our group previously showed that Wnt-4 mRNA was upregulated during oestrogen-induced lactotroph hyperplasia in Fischer 344 rats. Wnt molecules are key regulatory proteins controlling differentiation, proliferation and migration in development and adult life. Wnt-4 is involved in the emergence of lactotrophs during development, and has been implicated in pituitary tumour formation. Wnt molecules signal through three pathways. The well studied canonical pathway has been implicated in numerous cancers and centres around gene transcription initiated by translocation of β-Catenin into the nucleus. There are two non-canonical pathways: the Wnt-planar cell polarity (PCP) pathway and the Wnt-calcium pathway which are both poorly understood. In this thesis, the expression of Wnt-4 was studied in the pituitary, and effects of downstream signalling pathways in response to oestrogen were assessed. Wnt-4 was expressed in all secretory cell types of the pituitary, as well as the marginal zone (MZ), a region of the pituitary that may harbour stem cells. Oestrogen upregulated Wnt-4 protein in the somatolactotroph GH3 cell line, though this could not be replicated in primary tissue. A number of approaches (western blotting, immunofluorescence, reporter gene assays and mutant β-Catenin overexpression) were utilised to show that the canonical pathway was not activated in the pituitary. Wnt-4 had a clear inhibitory effect on calcium oscillations in GH3 cells, showing for the first time a non-canonical effect in the pituitary, though the downstream effects are currently unknown. Attempts made to study the activation of the PCP pathway were inconclusive. Efforts focused on the distribution of key structural and regulatory proteins in the anterior pituitary and the MZ. The MZ was characterised by a single layer of cells at the border of the anterior and intermediate lobes of the pituitary, with high expression of E-Cadherin and Sox 9, though no change in distribution was observed with oestrogen treatment. In the anterior lobe, oestrogen treatment decreased N and E-Cadherin expression, which could be an indicator of PCP pathway activation during oestrogen induced-lactotroph hyperplasia. Overall, data suggest that Wnt-4 does not directly cause oestrogen-induced lactotroph proliferation, but is likely to play a role in regulating tissue plasticity in the adult gland, as well as in the pathogenesis of pituitary tumours.

PURPOSE: Uveal melanoma (UM) is the most common intraocular malignancy in adults with an incidence of six per one million individuals each year. Globe conserving treatments are currently the standard of care, but unfortunately, despite successful local control, a substantial mortality risk exists due to eventual emergence of distant metastasis, which is invariably lethal. There is therefore an unmet need for novel, effective, targeted therapies for metastatic UM. Somatic mutations in the G-protein α subunits, Gαq and Gα, are present in a mutually exclusive pattern in approximately 80% of UMs, and they abolish the GTPase activity, resulting in a constitutively active protein. We have previously demonstrated that GNAQ-mutant (GNAQ^mt) UMs are addicted to the oncogenic effect of the mutant GNAQ protein and dissected the GNAQ pathway in an attempt to identify druggable targets. Our findings that the mutant GNAQ protein activates the PKC/PKD axis, which activates beta-catenin (β-Catenin), prompted us to investigate the role of PKC and β-Catenin in GNAQ^mt UM. EXPERIMENTAL DESIGN: The GNAQ^mt UM cell lines Mel202 and OMM1.3 were treated with either the PKC inhibitor bisindolylmaleimide I (BIM) alone, the Wnt/β-Catenin inhibitors FH535 or cardamonin alone, the Wnt/β-Catenin activator Wnt-3a alone, or siRNAs for β-Catenin in combination with BIM, and their viability was assessed with the MTT assay. Levels of β-Catenin, phosphorylated AKT, ERK1/2, caspase 3 and LC3BII were assessed with western blotting. β-Catenin mRNA levels were assessed with microarray analysis and RT-PCR. RESULTS: GNAQ^mt UM cells are very sensitive to PKC inhibition and respond with a decrease in cell viability that involves autophagy and cleavage and translocation of LC3BII in autophagosomes, but not caspase activation. PKC inhibition results in the upregulation of β-Catenin protein, but not mRNA levels, through a post-translational mechanism that involved the phosphorylation and activation of AKT, but not ERK1/2. β-Catenin inhibition by either small molecule inhibitors or siRNA resulted in a dose-dependent increase of cell proliferation, whereas β-Catenin activation by Wnt-3a had the opposite effects, resulting in a decrease in cell viability. CONCLUTIONS: Our study demonstrates that PKC is a mediator of the oncogenic effect of mutant Gα protein in UM through the Wnt-3/β-Catenin signaling pathway. These results open exciting opportunities for the development of personalized targeted therapies for UM in a genotype-dependent fashion.

Adenoviruses are non-enveloped, dsDNA tumor viruses responsible for a breadth of pathogenesis including acute respiratory disease and viral myocarditis. Gap junctions, which are formed by connexin proteins, directly couple the cytoplasms of apposed cells enabling immunological, metabolic, and electrical intercellular communication. The gap junction protein connexin43 (Cx43; gene name – GJA1) is the most widely expressed human connexin protein and is the predominant connexin in the working myocardium. Given the immunological role for Cx43 gap junctions, we hypothesized that gap junctions would be targeted during adenoviral infection. We find reduced Cx43 protein due to suppression of GJA1 transcription dependent upon β-catenin during adenoviral infection, with viral protein E4orf1 sufficient to induce β-catenin phosphorylation. Loss of gap junction function occurs prior to reduced Cx43 protein levels with Ad5 infection rapidly inducing Cx43 phosphorylation at residues previously demonstrated to alter gap junction conductance. Direct Cx43 interaction with ZO-1 plays a critical role in gap junction regulation. We find loss of Cx43/ZO-1 complexing during Ad5 infection by co-immunoprecipitation, with complementary studies in human induced pluripotent stem cell derived-cardiomyocytes revealing Cx43 gap junction remodeling concomitant with reduced ZO-1 complexing. These findings demonstrate specific targeting of gap junction function by Ad5 leading to disruptions in intercellular communication which would contribute to dangerous pathological states including arrhythmias in infected hearts. Intercellular junction proteins belonging to classically defined unique junctions exhibit extensive cross-talk and interdependency for expression and localization. We find reduced connexin43 (Cx43) phosphorylation at a known internalization motif, leading us to hypothesize that gap junctions are maintained during adenoviral infection in order to stabilize intercellular junctions and adenoviral receptors therein. Utilizing immunofluorescence confocal microscopy, we demonstrate that Cx43 reductions are primarily cytosolic with Cx43 preservation at the plasma membrane. Click-IT chemistry, a non-radioactive pulse-chase technique, reveals that Cx43 ½ life is extended during adenoviral infection. In order to test if remaining Cx43 exists in de facto gap junctions (i.e. not undocked or cytosolic connexons) we utilized 1 % Triton X-100 solubility fractionation and find Cx43 is indeed primarily junctional during adenoviral infection. Having demonstrated increases in junctional Cx43, we next asked how tightly coupled cells were during adenoviral infection and by ECIS measurements of electrical resistance we demonstrate a transient increase in mechanical coupling during infection. Our future aims are to uncover changes in Coxsackievirus and adenovirus receptor (CAR) protein localization to determine if adenoviral-induced changes to subcellular architecture predisposes neighboring cells to infection and enhances viral spread. These findings will add to the existing model of adenoviral infection and more broadly, contribute to the therapeutic design of adenoviral vectors for cancer and gene therapy. / Doctor of Philosophy / The human heart will beat more than 3 billion times during the average lifetime. This is accomplished by billions of individual heart muscle cells, called cardiomyocytes, contracting in synchrony. Cardiomyocytes require direct cell to cell communication in order to receive the proper cues and work in concert. Outside of the heart, including the lining of the lungs which acts as a first line of defense against invading pathogens, direct cell to cell communication is important for mounting proper immune responses. A primary means by which cells communicate directly with neighboring cells is through gap junctions which are formed of proteins called connexins. Six connexin proteins form a channel in the cell surface that binds to a similar channel on an apposing cell to create a continuous gap junction channel, coupling the cell interiors directly. The most widely expressed human connexin, and the most abundant connexin in the heart, is connexin43 (Cx43; gene name – GJA1). Adenoviruses are pathogens commonly associated with respiratory illnesses in addition to more serious diseases including viral myocarditis, or infection of the heart. Given that Cx43 gap junctions enable direct intercellular communication important in initiating immune responses, we hypothesized that adenovirus would target Cx43 and gap junctions during infection. We find reduced Cx43 protein in cells infected with human adenovirus, and revel that the expression of the GJA1 gene is suppressed. We next focused on potential signaling pathways that are changed during adenoviral infection. β-catenin is a factor with several cellular roles including regulating expression of specific genes including GJA1 (Cx43). We demonstrate β-catenin is activated during adenoviral infection and that this is necessary for reducing Cx43 transcripts. A pathway that activates β-catenin in this manner is the PI3K/Akt signaling axis, which has previously been shown to be turned on during adenovirus infection by a viral protein called E4orf1. We find the adenoviral protein E4orf1 is sufficient to induce β-catenin activation revealing a potential therapeutic target for future studies. We next determined that direct cell to cell communication through gap junctions is reduced before loss of the gap junction protein Cx43 during infection. Gap junctions are modified by the cell to change their ability to couple cells independently of protein levels alone and we find gap junction modifications consistent with altered communication ability. Furthermore, the gap junction protein Cx43 interacts with the cellular skeleton protein Zonula Occludens-1 (ZO-1) during movement into and out of gap junction clusters. We determined alterations in Cx43/ZO-1 interactions consistent with gap junction remodeling. In complimentary studies we find the same gap junction remodeling in cardiomyocytes revealing arrhythmogenic potential during acute adenoviral infection in human heart cells. Localized with gap junctions are several other junction proteins including the Coxsackievirus and adenovirus receptor (CAR) which is critical in cardiac development and also the primary receptor for species C adenoviruses (used in our studies). CAR expression has been demonstrated to alter Cx43 levels and indeed, many junctional proteins influence the expression and/or localization of other junctional proteins. Interestingly, despite reduced Cx43 levels and reduced gap junction function (cell to cell communication), we detected decreases in a gap junction modification that is associated with gap junction degradation, suggesting that new gap junction protein Cx43 is not being made but already synthesized Cx43 is degraded more slowly. We hypothesized Cx43 is maintained during adenoviral infection in order to recruit other junctional components, principally CAR, on uninfected neighbor cells to predispose them to infection. We observed using microscopy that Cx43 reductions are primarily inside the cell but Cx43 is preserved on the cell surface and at junctions between cells. We next asked if the protein is being degraded more slowly and find Cx43 exists for longer in infected cells signifying that it is being degraded more slowly. Utilizing a fractionation technique to separate gap junction connexin from connexon that is non-junctional or inside the cell, we detect an increase in junctional Cx43, revealing maintenance of Cx43 gap junction structures. Having now identified adenoviral-mediated maintenance of Cx43 gap junction structures, we next wanted to test for changing in mechanical coupling (i.e. how tightly are the cells connected to one another) where we demonstrate an increase in mechanical coupling during adenoviral infection. Our future directions are to determine if this increase in Cx43 gap junction maintenance and mechanical coupling is concomitant with changes in CAR expression/localization on uninfected neighboring cells and if altered, does this predispose uninfected neighbors of infected cells to infection.